FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma

Simone Lubrano(University of California San Diego), J. Silvio Gutkind(National Institutes of Health)
Cancer Cell
February 27, 2025
Cited by 34


Related Papers